Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide dosing can seem confusing when you see measurements in both units and milligrams. A 40-unit dose of tirzepatide contains exactly 1.2 milligrams of the medication. PlexusDx compounded tirzepatide injections follow standard pharmaceutical dosing conventions to ensure safety and efficacy.
Converting 40 Units of Tirzepatide to Milligrams
The conversion between units and milligrams for tirzepatide follows a straightforward mathematical relationship. Forty units of tirzepatide equals 1.2 milligrams (mg) of the active pharmaceutical ingredient. This ratio holds true across all tirzepatide formulations, whether manufactured by pharmaceutical companies or prepared by licensed compounding pharmacies. Understanding this conversion helps you track your exact dose each week and compare different formulation options.
Many patients receive tirzepatide in weekly injections that gradually increase over time. Starting doses typically begin around 2.5 to 5 units per week, then scale upward in incremental steps. If your healthcare provider prescribes a 40-unit injection, you can confidently know you're receiving 1.2 mg of tirzepatide. This transparency matters because it connects the injection volume you see to the actual medication dose being delivered into your body.
Understanding Tirzepatide Dosing Schedules and Progression
Tirzepatide therapy typically follows a four-step dosing escalation protocol designed to minimize side effects while building tolerance. Week one through four involve a 2.5-unit starting dose, equivalent to 0.075 mg. The second month increases to 5 units (0.15 mg), the third month to 10 units (0.30 mg), and the fourth month to 15 units (0.45 mg). Some patients continue escalating to 20, 30, or 40 units depending on their response and tolerance. PlexusDx works with your provider to identify your optimal maintenance dose without charging more as your units increase.
The reason for gradual dose escalation centers on gastrointestinal adaptation and medication tolerance. Starting low gives your body time to adjust to how tirzepatide affects appetite signaling and glucose metabolism. Higher doses like 40 units deliver stronger appetite suppression and metabolic improvements but may initially cause nausea or other side effects. Your personalized dosing path depends on your weight loss goals, baseline health markers, and individual response patterns.
How PlexusDx Tirzepatide Injections Support Personalized Dosing
PlexusDx compounds tirzepatide injections through licensed 503A compounding pharmacies that meet rigorous pharmaceutical standards. Each injection is calibrated to deliver precise unit measurements, whether you're at a 2.5-unit starting dose or a 40-unit maintenance dose. The pricing structure means your monthly cost remains flat as your dose increases—your dose may need to go up, but your price won't. Compounded tirzepatide injections start at $249 per month across all dosing tiers, with no hidden fees or dose-based surcharges.
Beyond standard dosing, PlexusDx offers the Precision Peptide Genetic Test to reveal how your unique genetic makeup influences response to tirzepatide therapy. The test examines 14 peptide-related pathways including the GLP1R rs6923761 variant, which affects how sensitive your receptors are to tirzepatide signaling. The GIPR rs1800437 variant influences your glucose-dependent insulinotropic polypeptide response. Understanding these genetic insights helps your provider fine-tune whether 40 units is truly optimal for your body or whether a different dose or medication like semaglutide might serve you better.
Clinical Evidence Behind Tirzepatide Dosing Tiers
The tirzepatide clinical trial program (SURPASS series) tested doses ranging from 5 mg to 15 mg weekly, which correspond to approximately 17 to 50 units. Participants receiving the highest doses showed average weight loss of 20% to 22% of baseline body weight over one year. These results demonstrated that higher tirzepatide doses produce dose-dependent weight loss and metabolic improvements, though they also correlated with increased nausea in early treatment phases. The data supports the gradual escalation strategy that allows patients to reach effective doses while managing tolerability.
A 40-unit dose (1.2 mg) falls within the therapeutic range tested in major trials and reflects a meaningful mid-to-high tier of tirzepatide therapy. Some patients achieve target weight loss at lower doses, while others benefit from continuing toward the maximum studied dose. The key clinical principle is that tirzepatide works along a dose-response curve—more medication generally produces stronger effects, but individual variation exists. PlexusDx's approach involves monitoring your progress and adjusting your dose based on actual results rather than assuming every patient needs identical amounts.
Tirzepatide Dosing Transparency and Patient Safety
Knowing that 40 units equals 1.2 milligrams empowers you to understand exactly what medication you're receiving each week. This transparency supports informed decision-making and helps you track side effects or metabolic changes relative to your dose. When you receive tirzepatide from a licensed 503A compounding pharmacy through PlexusDx, you get detailed documentation of your compounded formulation, including the exact amount of active ingredient in each injection. This accountability ensures safety and allows seamless coordination between you, your prescriber, and your pharmacy.
If you experience unexpected reactions or need to pause treatment, having clarity about your dose helps your healthcare team make appropriate adjustments. A 40-unit dose is substantially higher than starting doses and represents an advanced step in your weight loss journey. Communicating your exact dose in both units and milligrams to any healthcare provider—not just your weight loss specialist—ensures continuity of care and reduces medication errors. PlexusDx prioritizes this communication by providing clear dosing documentation with every shipment.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the exact conversion between tirzepatide units and milligrams?
Forty units of tirzepatide equals 1.2 milligrams of the medication. The conversion rate is consistent: every 33.3 units equals 1 milligram. This ratio applies to all tirzepatide formulations, including those from licensed 503A compounding pharmacies like those used by PlexusDx.
Why does tirzepatide dosing increase over weeks and months?
Gradual dosing escalation allows your digestive system and metabolic receptors to adapt to tirzepatide's effects. Starting low reduces initial nausea and other side effects while your body builds tolerance. The typical progression moves from 2.5 units to 5, 10, 15, and potentially higher doses depending on your response and goals.
Does PlexusDx charge more as my tirzepatide dose increases?
No. PlexusDx compounded tirzepatide injections are priced at a flat $249 per month regardless of whether your dose is 2.5 units or 40 units. Your dose may need to go up, but your price won't—there are no dose-based surcharges or escalating fees.
Is a 40-unit tirzepatide dose considered safe and effective?
Yes. The SURPASS clinical trials tested tirzepatide doses up to approximately 50 units (15 mg) and demonstrated strong safety and efficacy profiles. A 40-unit dose falls well within the tested therapeutic range and produced average weight loss of 20% or more in trial participants.
How can the Precision Peptide Genetic Test help with my tirzepatide dosing?
PlexusDx's Precision Peptide Genetic Test examines variants like GLP1R rs6923761 and GIPR rs1800437 that influence how your body responds to tirzepatide at different doses. These insights help your provider determine whether 40 units is optimal for you or whether a different dose level or medication might work better based on your genetic predispositions.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can My Doctor Prescribe Tirzepatide for Weight Loss?
Can You Gain Weight While Taking Ozempic? Understanding the Complexities